India’s regulator has approved a new, oral COVID-19 drug that promises to reduce hospitalisation time and oxygen dependency for moderate to severe cases, reports the Economic Times.
The first 10,000 doses are expected to be available by next week.
Effective COVID-19 vaccineThe 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation has proved to be effective in three phases of trials on COVID-19 patients and can be easily mass produced, officials said, adding...
https://mfame.guru/new-covid-drug-developed-by-drdo-receives-emergency-authorization/